Hypertension Flashcards

1
Q

When assessing a patient with newly diagnosed hypertension, what are important areas to address?

A
  • Concomitant CVS risk factors
  • Consider secondary causes if appropriate
  • Assess for target organ damage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cardiovascular risk factors

A
Non-modifiable:
- Age
- Gender (Male > female)
- Family hx
- Race
Modifiable:
- Obesity
- Hypertension
- Hyperlipidaemia
- Alcohol
- Smoking
- Diabetes/ metabolic syndrome
-Sedentary lifestyle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When to consider secondary causes of HTN?

A
  • Pt <40yo
  • Sudden changes in BP in previously well managed patient
  • Rapid onset of HTN
  • Resistant HTN, unresponsive to meds
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are secondary causes of HTN and what are features suggestive of each?

A

Renal artery stenosis: pulmonary oedema, widespread atherosclerosis (bruits)
Nephrotic syndrome: oedema, foamy urine
Obstructive uropathy: Prostatic enlargement, previous urethral instrumentation, renal calculi
CKD: Hx of renal impairment, uraemic sx
Coarctation of the aorta: poor feeding in children, radiofemoral delay, cold peripheries
Polycystic kidney disease: fhx of polycystic kidney, intracranial aneurysms, sub-arachnoid haemorrhages
- Hyperaldosteronism: Sx of low potassium (headaches, nocturia, parasthesiae)
- Cushing’s: Depression, wt gain, hirsutism, easy bruising, low libido, moon facies, buffalo hump, hyperglycaemia, osteporosis, etc.
- Hyperthyroidism: heat intolerance, sweating, palpitations, diarrhoea, wt loss, etc.
- Hypothyroidism: Depression, wt gain, constipation, etc.
- Hyperparathyroidism: Bone pain, parasthesiae, myalgia
- Toxic cause: OCP, NSAIDs, alcohol, other meds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Assessment of target organ damage in the hypertensive patient.

A

CVD
- CCF: any SOB, PND, orthopnoea, ankle oedema.
- IHD: chest pain/angina
- O/E: displaced apex beat, murmurs, thrills, heaves, pulmonary oedema
- LVH dx on ECG
Cerebrovascular Disease
- Ask about sx suggestive of CVA/TIA–> speech difficulties, visual disturbances, transient focal neurology (weakness)
- O/E: Carotid bruits, residual functional loss
Renal failure
- May be asymptomatic, pay have polyuria or oligouria, pruritus, lethargy, wt loss, nausea, vomiting, loss of appetite
Retinopathy
- Mostly asymptomatic, may have headaches or visual changes
- O/E: fundoscopy for hypertensive retinopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Initial investigations for patient with newly dx HTN?

A
  • ECG: signs of previous MI, LVH (important prognostic factor), strain pattern (ST depression and T-wave inversion)
  • Echo: if clinical suspicion of HF
  • CXR: cardiomegaly
  • Bloods: UEC with random BSL (kidney function {need to know baseline before commencing antihypertensive}, stratify risk), cholesterol, fasting BSL if diabetes suspected, LFTs if alcohol suspected, TFTs if thyroid suspected
  • Urine dipstick: glycosuria, proteinuria, casts.
  • Urinalysis: assessment of microalbuminuria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Physical examination on a patient with diagnosed HTN.

A

General Inspection:Body habitus
Vitals: BP, HR rhythm and character, RR, Temp, BMI, BSL
Hands: CRT, warm peripheries, nicotine staining
Face: Cushingoid or thyroid features
Neck: Elevated JVP, carotid bruits
Chest: Apex beat, thrills, heaves, heart sound (extra heart sounds, murmurs)
Back: auscultate lung bases for fluid
Abdo: hepatomegaly, ascites, pulsatile liver, abdominal aortic aneurysm, palpable kidneys (CKD), renal bruits
Legs: Absent femoral pulses, radiofemoral delay, peripheral oedema, peripheral pulses
Fundoscopy for hypertensive retinopathy
Neuro exam for focal neurological signs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

ACE Inhibitor MOA

A

Blocks conversion of angiotensin I to angiotensin II, thereby reducing the effects of angiotensin II-induced vasoconstriction (reduced peripheral vascular resistance), sodium retention (reduced fluid load) and aldosterone release (reduced sodium and water retention)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ACE inhibitor Adverse effects

A

Common: hypotension, cough, hyperkalaemia, headaches, dizziness, fatigue, nausea, renal impairment.
Infrequent: Angiodema, anaphylaxis. Can rarely cause liver damage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How to counsel a patient starting an antihypertensive medication.

A

Take the tablet at the same time every day. Most are a once daily dose.
You may feel dizzy when you start taking this medication. Get up gradually from sitting or lying to minimise this effect. Sit or lie down if you become dizzy or light-headed. For ACEI and ARB: Do not take potassium supplements while taking this medication.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ARB MOA

A

Competitively block binding of angiotensin II to type I angiotensin (AT1) receptors. Reducing angiotensin-induced vasoconstriction, sodium reabsorption and aldosterone release.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Side effects of ARBs.

A

Common: Dizziness, headache, hyperkalaemia.
Infrequent: First dose hypotension, rash, diarrhoea, dyspepsia, abnormal LFTs, muscle aches and pains.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MOA of thiazide diuretics.

A

Moderately potent diuretics. Inhibit reabsorption of sodium and chloride in the proximal segment of the distal convoluting tubule and produce a corresponding increase in potassium excretion –> lowers BP mostly by vasodilator effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Side effects of thiazide diuretics.

A

Common: Dizziness, weakness, muscle cramps, polyuria, hypotension, hyponatraemia, hypokalaemia, hyperuricaemia, hypochloricaemic alkalosis, hypomagnesaemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Calcium channel blockers MOA

A

Block inward current of calcium into cells in vascular smooth muscle, myocardium, and cardiac conducting system via L-type calcium channels. Dihydropyridines act mostly on smooth muscle. Verapamil has greater cardiac effect (reduces contractility, HR and contraction with less effect on smooth muscle). Diltiazem acts on both.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Adverse effects of calcium channel blockers.

A

Common: (esp dihydropyridines) headache, flushing, peripheral oedema, palpitations. bradycardia (diltiazem, verapamil), constipation(verapamil)

17
Q

MOA of beta blockers

A

Competitively block beta receptors in heart, peripheral vasculature, bronchi, pancreas, uterus, kidney, brain and liver, Antihypertensive effect due to reduction in cardiac output without reflexive increase in peripheral vasculature resistance.

18
Q

Adverse effects beta blockers

A

Nausea, diarrhoea, dyspnoea, bronchospasm, cold extremities, exacerbation of Raynaud’s phenomenon, bradycardia, hypotension, heart failure, heart block, fatigue, dizziness, abnormal vision, decreased concentration, hallucinations, insomnia

19
Q

Drugs that may cause an increase in BP.

A

Corticosteroids
NSAIDs
OCP
Also clozapine, haemopoetic agents, immunomodifiers, MAO inhibitors, oral decongestants, stimulants, venlafaxine

20
Q

Drug classes for first line management of HTN

A

ACEI, ARB
Thiazide diuretic
Calcium channel blocker

Beta blocker not first line though does have a role in HF

21
Q

When to intervene in patients with confirmed HTN

A
  • Should be based on thorough clinical evaluation to identify associated clinical conditions and end-organ damage and assessment of CVD risk
    Initiate antihypertensive treatment immediately in any patients with the following:
  • Grade 3 hypertension (>180 systolic, >110 diastolic) or isolated systolic with widened pulse pressure (SBP >160 and DBP <70)
  • Associated conditions or evidence of end-organ damage
  • Moderate to high absolute cardiovascular risk
  • Consider if ATSI